Baseline Genomic Features in BRAFV600-Mutated Metastatic Melanoma Patients Treated with BRAF Inhibitor + MEK Inhibitor in Routine Care - DATASET

These data relate to Baseline Genomic Features in BRAFV600-Mutated Metastatic Melanoma Patients Treated with BRAF Inhibitor + MEK Inhibitor in Routine Care https://www.mdpi.com/2072-6694/11/8/1203.

Conceptualization, Baptiste Louveau, Fanelie Jouenne, Samia Mourah, and Celeste Lebbe; Methodology, Baptiste Louveau and Fanelie Jouenne; Formal analysis, Bapiste Louveau, Fanelie Jouenne, Coralie Reger de Moura, and Aurélie Sadoux; Investigation, Baptiste Louveau, Fanelie Jouenne, Coralie Reger de Moura, and Aurélie Sadoux; Validation: Coralie Reger de Moura and Aurélie Sadoux; Resources, Barouyr Baroudjian, Julie Delyon, Florian Herms, Adele De Masson, Laetitia Da Meda and Maxime Battistella; Writing—original draft preparation, Baptiste Louveau. and Fanelie Jouenne; Writing—review and editing, Nicolas Dumaz, Celeste Lebbe and Samia Mourah; Visualization, Baptiste Louveau; Supervision, Celeste Lebbe and Samia Mourah; Project administration, Celeste Lebbe and Samia Mourah;

The dataset was deposited by Romain Larive, University of Montpellier (orcid 0000-0001-8479-209X) and Sarah Dandou, University of Montpellier (orcid 0000-0003-4786-5928)